Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Laco

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
The Journal of Molecular Diagnostics : JMD|January 27, 2024
Somatic Genomic and Transcriptomic Characterization of Primary Ovarian Serous Borderline Tumors and Low-Grade Serous CarcinomasIvana Stružinská, Nikola Hájková, Jan Hojný, et al.
Diagnostic Pathology|February 5, 2023
A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumorsKristýna Němejcová, Michaela Kendall Bártů, Romana Michálková, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2019
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian CancerJitka Fucikova, Jana Rakova, Michal Hensler, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 5, 2023
Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 CasesMichaela Kendall Bártů, Kristýna Němejcová, Romana Michálková, et al.
Virchows Archiv : an International Journal of Pathology|May 13, 2022
The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significancePavel Dundr, Barbora Bazalová, Michaela Bártů, et al.
The American Journal of Surgical Pathology|January 6, 2025
Molecular Profiling of Sinonasal Adenoid Cystic Carcinoma: Canonical and Noncanonical Gene Fusions and MutationAlena Skálová, Martina Bradová, Abbas Agaimy, et al.
Pathology|July 27, 2023
Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significancePavel Dundr, Nikola Hájková, Michaela Kendall Bártů, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|May 27, 2023
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genesNikola Hájková, Michaela Kendall Bártů, David Cibula, et al.
Translational Oncology|January 19, 2024
Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervixLucie Pavelková, Eliška Táborská, Linn A Syding, et al.
The American Journal of Surgical Pathology|April 18, 2023
Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading SystemMartina Baněčková, Lester D R Thompson, Martin D Hyrcza, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
The Journal of Molecular Diagnostics : JMD|January 27, 2024
Somatic Genomic and Transcriptomic Characterization of Primary Ovarian Serous Borderline Tumors and Low-Grade Serous CarcinomasIvana Stružinská, Nikola Hájková, Jan Hojný, et al.
Diagnostic Pathology|February 5, 2023
A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumorsKristýna Němejcová, Michaela Kendall Bártů, Romana Michálková, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2019
TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian CancerJitka Fucikova, Jana Rakova, Michal Hensler, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 5, 2023
Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 CasesMichaela Kendall Bártů, Kristýna Němejcová, Romana Michálková, et al.
Virchows Archiv : an International Journal of Pathology|May 13, 2022
The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significancePavel Dundr, Barbora Bazalová, Michaela Bártů, et al.
The American Journal of Surgical Pathology|January 6, 2025
Molecular Profiling of Sinonasal Adenoid Cystic Carcinoma: Canonical and Noncanonical Gene Fusions and MutationAlena Skálová, Martina Bradová, Abbas Agaimy, et al.
Pathology|July 27, 2023
Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significancePavel Dundr, Nikola Hájková, Michaela Kendall Bártů, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|May 27, 2023
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genesNikola Hájková, Michaela Kendall Bártů, David Cibula, et al.
Translational Oncology|January 19, 2024
Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervixLucie Pavelková, Eliška Táborská, Linn A Syding, et al.
The American Journal of Surgical Pathology|April 18, 2023
Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading SystemMartina Baněčková, Lester D R Thompson, Martin D Hyrcza, et al.
Pageof 18